05/06/2026
The science is moving forward.
The clinical trials are waiting.
So why aren't enough people enrolling? 🧠💊
Here's a truth that doesn't get talked about enough:
Clinical trials sometimes fail — not because the science is wrong, but because not enough of the right people sign up.
And for too long, recruitment has been treated like a paperwork problem instead of what it really is: a mission-critical lifeline for people living with Parkinson's.
Steve DeWitte and Michelle Morianos Hespeler know this better than almost anyone. They've lived with PD for nearly 20 years.
They've watched promising trials stall. They've felt the frustration of a system that wasn't built with patients at the center.
Shouldn't that end - now?
CureNow:PD wants a smarter, more human recruitment system — one that includes:
✅ Clear priorities and shared metrics
✅ Plain-language outreach (in MULTIPLE languages)
✅ Trusted community ambassadors
✅ Real-time recruitment dashboards
✅ Participant feedback loops
✅ Standard playbooks — and a commitment to getting better every single day
Because Parkinson's research can move faster.
It can work better.
And people living with PD deserve nothing less.
